Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PharmX TechnologiesASX:PHX Cash Ratio is 0.83 as of Jun. 2026, which is 24% below its 10-year median of 1.09. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, PharmX Technologies ranks better than 82.78% on this metric.
PharmX Technologies has a Cash Ratio of 0.83. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for PharmX Technologies's Cash Ratio or its related term are showing as below:
ASX:PHX'
s Cash Ratio Range Over the Past 10 Years
Min: 0.42 Med: 1.09 Max: 4.23
Current: 2.26
During the past 13 years, PharmX Technologies's highest Cash Ratio was 4.23. The lowest was 0.42. And the median was 1.09.
ASX:PHX's Cash Ratio is ranked better than 82.78% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 0.58
vs ASX:PHX: 2.26
PharmX Technologies (ASX:PHX) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
PharmX Technologies Cash Ratio Related Terms
PharmX Technologies Cash Ratio Historical Data
* Premium members only.
The historical data trend for PharmX Technologies's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, PharmX Technologies's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmX Technologies Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's Cash Ratio distribution charts can be found below:
* The bar in red indicates where PharmX Technologies's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmX Technologies (ASX:PHX) has a Cash Ratio of 0.83 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on PharmX Technologies and its competitors. This is 24% below median its historical median of 1.09. Over the past decade, PharmX Technologies' Cash Ratio has ranged from 0.42 to 4.23. According to the industry distribution chart, PharmX Technologies ranks #115 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 17.2%.
Is PharmX Technologies' Cash Ratio too high?
PharmX Technologies' current Cash Ratio of 0.83 is 24% below median its 10-year median of 1.09. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 4.23. The Healthcare Providers & Services industry median Cash Ratio is 0.58. PharmX Technologies' value of 0.83 is 43.1% above this industry median. Based on the distribution chart, PharmX Technologies ranks #115 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does PharmX Technologies' Cash Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, PharmX Technologies ranks #115 out of 668 companies for Cash Ratio. This places PharmX Technologies in the top 17% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.58. PharmX Technologies' value of 0.83 is 43.1% above this benchmark. Historically, PharmX Technologies' own Cash Ratio has ranged from 0.42 to 4.23 over the past decade. While the company's 10-year median is 1.09 vs. the industry median of 0.58, PharmX Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.58, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmX Technologies's current Cash Ratio of 0.83 is 43.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on PharmX Technologies and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmX Technologies's current Cash Ratio is 0.83, which is 24% below median its own 10-year median of 1.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmX Technologies stock overvalued right now?
Based on GuruFocus' analysis, PharmX Technologies (ASX:PHX) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.07, compared to a current price of A$0.09 — trading 25.7% above its estimated fair value. The current Cash Ratio is 0.83, which is 24% below median its 10-year median of 1.09 and 43.1% above the Healthcare Providers & Services industry median of 0.58. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For PharmX Technologies (ASX:PHX), the current Cash Ratio is 0.83 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PHX has been successfully added to your 
